Clinical Trial Update: Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Aldesleukin with or without vaccine therapy in locally advanced or metastatic melanoma has completed, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Proleukin (aldesleukin) (aldesleukin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Melanoma, Stage IIIA Skin Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2017-11-20